1. High but not low self-reported statin adherence was confirmed by a novel method based on plasma-statin measurements in coronary outpatients. (11th May 2021) Authors: Kristiansen, O; Sverre, E; Peersen, K; Fagerland, MW; Gjertsen, E; Gullestad, L; Perk, J; Dammen, T; Husebye, E; Vethe, NT; Munkhaugen, J Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Low-density lipoprotein cholesterol increased significantly after short-term discontinuation of atorvastatin, but did not correlate with plasma drug concentrations. (11th May 2022) Authors: Sverre, E; Piourevonas, J; Kristiansen, O; Peersen, K; Lauritzen, T; Husebye, E; Fagerland, M; Vethe, NT; Munkhaugen, J Journal: European journal of preventive cardiology Issue: Volume 29(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Tailored clinical management after blinded statin challenge improved long-term lipid control in coronary patients with self-perceived muscle side-effects. (11th May 2021) Authors: Sverre, E; Peersen, K; Kristiansen, O; Fagerland, MW; Perk, J; Husebye, E; Vethe, NT; Dammen, T; Munkhaugen, J Journal: European journal of preventive cardiology Issue: Volume 28:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗